Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Levenson

Showing results (191-200 of 2,525) with videos related to

Pageof 253
Sort By:
American Journal of Medical Genetics. Part A|February 26, 2013
Prenatal peptide treatment appears promising in Down syndrome mouse modelDeborah Levenson
American Journal of Medical Genetics. Part A|November 24, 2012
Genetic modifier to chromatin may contribute to 22q11 deletion/VCF/DiGeorge syndrome variability: MOZ gene may also exacerbate effects of retinoic acid in genetic disorderDeborah Levenson
American Journal of Medical Genetics. Part A|November 24, 2012
Newborn screening for Duchenne muscular dystrophy gains support: researchers to push for federal recommendation to have states add DMD test to newborn panelDeborah Levenson
NLN Publications|January 1, 1979
Use of patient statistics for program planningG Levenson
NLN Publications|October 5, 1970
Home health agency operations. Time and cost study problemsG Levenson
Social Work|July 18, 2020
Translating Trauma-Informed Principles into Social Work PracticeJill Levenson
The Senior Care Pharmacist|January 24, 2024
Antipsychotics: Past, Present, and Future (Part 2): Article 2 of 3Steven Levenson
Journal of the American Medical Directors Association|February 1, 2024
Antipsychotics in Perspective: Past, Present, and Future (Article 2 of 3)Steven Levenson
American Journal of Medical Genetics. Part A|February 24, 2011
Should 22q11 deletion be added to newborn screening panels?Deborah Levenson
American Journal of Medical Genetics. Part A|December 20, 2013
Whole-exome sequencing emerges as clinical diagnostic tool: testing method proves useful for diagnosing wide range of genetic disordersDeborah Levenson
Pageof 253

Showing results (191-200 of 2,525) with videos related to

Sort By:
Pageof 253
American Journal of Medical Genetics. Part A|February 26, 2013
Prenatal peptide treatment appears promising in Down syndrome mouse modelDeborah Levenson
American Journal of Medical Genetics. Part A|November 24, 2012
Genetic modifier to chromatin may contribute to 22q11 deletion/VCF/DiGeorge syndrome variability: MOZ gene may also exacerbate effects of retinoic acid in genetic disorderDeborah Levenson
American Journal of Medical Genetics. Part A|November 24, 2012
Newborn screening for Duchenne muscular dystrophy gains support: researchers to push for federal recommendation to have states add DMD test to newborn panelDeborah Levenson
NLN Publications|January 1, 1979
Use of patient statistics for program planningG Levenson
NLN Publications|October 5, 1970
Home health agency operations. Time and cost study problemsG Levenson
Social Work|July 18, 2020
Translating Trauma-Informed Principles into Social Work PracticeJill Levenson
The Senior Care Pharmacist|January 24, 2024
Antipsychotics: Past, Present, and Future (Part 2): Article 2 of 3Steven Levenson
Journal of the American Medical Directors Association|February 1, 2024
Antipsychotics in Perspective: Past, Present, and Future (Article 2 of 3)Steven Levenson
American Journal of Medical Genetics. Part A|February 24, 2011
Should 22q11 deletion be added to newborn screening panels?Deborah Levenson
American Journal of Medical Genetics. Part A|December 20, 2013
Whole-exome sequencing emerges as clinical diagnostic tool: testing method proves useful for diagnosing wide range of genetic disordersDeborah Levenson
Pageof 253